Baird Downgrades Tenet Healthcare (THC) to Neutral
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/16/2026
- S&P 500 ends higher as traders shift from AI to healthcare
- U.S. producer prices rise by 1.3% month-on-month in September
- Brent steady as US weighs easing sanctions on global 'shadow fleet'
- UBS now expects a third Fed rate hike after hot September inflation print
- Tesla-SpaceX Merger could be announced before December, Barclays says
Tweet
Share
E-mailGet Alerts THC Hot Sheet
Price: $275.13 +1.30%
Rating Summary:
24 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 13 | New: 42
Rating Summary:
24 Buy, 10 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 16 | Down: 13 | New: 42
Join SI Premium – FREE
Baird analyst Michael Ha downgraded Tenet Healthcare (NYSE: THC) from Outperform to Neutral with a price target of $137.00 (from $153.00).
For an analyst ratings summary and ratings history on Tenet Healthcare click here. For more ratings news on Tenet Healthcare click here.
Shares of Tenet Healthcare closed at $124.91 yesterday.
You May Also Be Interested In
- Goldman Sachs Downgrades Yunda Holding Co Ltd (002120:CH) to Sell
- Goldman Sachs Downgrades ZTO Express Cayman (2057:HK) (ZTO) to Neutral
- Canaccord Upgrades Lithium Americas Corp. (LAC:CN) (LAC) to Spec. Buy
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
